The Calan brand name has been discontinued in the U.S. for reasons unrelated to safety or efficacy. Other brand names or generic alternatives may be available. If you’re currently taking this medication, talk to your… read more
The Amerge brand name brand name has been discontinued in the U.S. for reasons unrelated to safety or efficacy. Other brand names or generic alternatives may be available. If you’re currently taking this medication, talk… read more
The Elavil brand name has been discontinued in the U.S. for reasons unrelated to safety or efficacy. Other brand names or generic alternatives may be available. If you’re currently taking this medication, talk to your… read more
The Inderal brand name has been discontinued in the U.S. for reasons unrelated to safety or efficacy. Other brand names or generic alternatives may be available. If you’re currently taking this medication, talk to your… read more
Overview
Eprontia is approved by the U.S. Food and Drug Administration (FDA) for the preventive treatment of migraine in people 12 years of age and older. It is used to help reduce the frequency of migraine headaches in…
read moreThe Covera-HS brand name has been discontinued in the U.S. for reasons unrelated to safety or efficacy. Other brand names or generic alternatives may be available. If you’re currently taking this medication, talk to your… read more
Overview
Depakote is approved by the U.S. Food and Drug Administration (FDA) for the prophylaxis (prevention) of migraine attacks in adults. Depakote is also known by its drug name, divalproex sodium.
Depakote is an…
read moreOverview
Qudexy XR is approved by the U.S. Food and Drug Administration (FDA) for the preventive treatment of migraine in people 12 years of age and older. It should be prescribed for people who experience frequent…
Overview
Inderal LA is approved by the U.S. Food and Drug Administration (FDA) for the prophylaxis (prevention) of common migraine headaches. It is used to reduce the frequency and severity of migraine attacks in adults…
read more